China SXT Pharmaceuticals, Inc. (SXTC) — Dilution Risk Analysis
Current Snapshot
China SXT Pharmaceuticals, Inc. (SXTC) has a DilutionWatch score of 38/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 38/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
1 shelf registration or ATM offering filing detected in recent history.
Recent filing forms in the source payload: 6-K 1, 424B5 1, XBRL 2.
| Form | Filed | Accession |
|---|---|---|
| 6-K | 2026-04-09 | 0001213900-26-041765 |
| 424B5 | 2026-04-09 | 0001213900-26-041766 |
| xbrl | 2025-03-31 | xbrl-7440-xbrl_convertible |
| xbrl | 2023-09-30 | xbrl-7440-xbrl_warrant |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| ATM offering capacity remaining | $760,000 | Source |
| Cash runway | 84 months | Source |
| Three-year share count growth | -16.21% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 38/10) Source
- Cash Runway
- 84 months Source
- ATM Offering Capacity Remaining
- $760,000 Source
- Share Count Growth (3-Year)
- -16.21% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.